Hematology Meeting Highlights

December 22, 2015
Cat Snyder, ASCO staff

Michael E. Williams, MD, ScM, the Cancer.Net Associate Editor for Lymphoma, recently attended the American Society of Hematology Annual Meeting. During the meeting, doctors discussed new treatment approaches for lymphomas and leukemias. Dr. Williams reports on the main highlights in this podcast: share on twitter 

  • Research comparing two targeted therapies, ibrutinib (Imbruvica) and temsirolimus (Torisel), for relapsed mantle cell lymphoma  [3:45]

  • Early studies that showed impressive results on various drugs for chronic lymphocytic leukemia and non-Hodgkin lymphoma [6:50]

This is a prerecorded audio podcast, and it can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.

Share your thoughts on this blog post on Cancer.Net's Facebook and Twitter.